These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1052 related articles for article (PubMed ID: 27328803)

  • 21. Prevalence and clinical significance of nonorgan specific antibodies in patients with autoimmune thyroiditis as predictor markers for rheumatic diseases.
    Elnady BM; Kamal NM; Shaker RHM; Soliman AF; Hasan WA; Alghamdi HA; Algethami MM; Jajah MB
    Medicine (Baltimore); 2016 Sep; 95(38):e4336. PubMed ID: 27661011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insight into the Epidemiology of the Adult-onset Systemic Autoimmune Rheumatic Diseases in Egypt: A Descriptive Study of 8690 Patients.
    Attia DHS; Mohamed ER; Ismaeel AY; Suliman YA; Moneim NHA; Abdel Noor RA
    Curr Rheumatol Rev; 2024; 20(5):522-533. PubMed ID: 38314595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody to extractable nuclear antigen in the rheumatic diseases.
    McCain GA; Bell DA; Chodirker WB; Komar RR
    J Rheumatol; 1978; 5(4):399-406. PubMed ID: 310883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiplexed AtheNA multi-lyte immunoassay for ANA screening in autoimmune diseases.
    Shovman O; Gilburd B; Zandman-Goddard G; Yehiely A; Langevitz P; Shoenfeld Y
    Autoimmunity; 2005 Feb; 38(1):105-9. PubMed ID: 15804711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-DFS70/LEDGF antibodies are more prevalent in healthy individuals compared to patients with systemic autoimmune rheumatic diseases.
    Mahler M; Parker T; Peebles CL; Andrade LE; Swart A; Carbone Y; Ferguson DJ; Villalta D; Bizzaro N; Hanly JG; Fritzler MJ
    J Rheumatol; 2012 Nov; 39(11):2104-10. PubMed ID: 22942262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period.
    Hayashi N; Koshiba M; Nishimura K; Sugiyama D; Nakamura T; Morinobu S; Kawano S; Kumagai S
    Mod Rheumatol; 2008; 18(2):153-60. PubMed ID: 18283522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autoantibody profile and clinical patterns in 619 Italian patients with cutaneous lupus erythematosus.
    Verdelli A; Coi A; Marzano AV; Antiga E; Cozzani E; Quaglino P; La Placa M; Benucci M; De Simone C; Papini M; Parodi A; Bianchi F; Caproni M
    J Eur Acad Dermatol Venereol; 2019 Apr; 33(4):742-752. PubMed ID: 29924416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
    Tipu HN; Bashir MM
    J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-nuclear antibodies in daily clinical practice: prevalence in primary, secondary, and tertiary care.
    Avery TY; van de Cruys M; Austen J; Stals F; Damoiseaux JG
    J Immunol Res; 2014; 2014():401739. PubMed ID: 24741596
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Speckled antinuclear antibodies in keratinocytes--what does it mean?
    Bukilica MN; Andrejevic SB; Bonaci-Nikolic BM; Nikolic MM
    Clin Exp Rheumatol; 2002; 20(4):499-504. PubMed ID: 12175105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dense fine speckled immunofluorescence pattern in a Chinese population: Prevalence and clinical association.
    Zhang K; Su Z; Hu J; Huang Z; Hu C; Yang B
    J Clin Lab Anal; 2022 Feb; 36(2):e24173. PubMed ID: 34952992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
    Sebastian W; Roy A; Kini U; Mullick S
    Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The antinuclear antibody dense fine speckled pattern and possible clinical associations: An indication of a proinflammatory microenvironment.
    Lundgren MC; Sapkota S; Peterson DJ; Crosson JT
    J Immunol Methods; 2021 Jan; 488():112904. PubMed ID: 33121975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered Th17 cells and Th17/regulatory T-cell ratios indicate the subsequent conversion from undifferentiated connective tissue disease to definitive systemic autoimmune disorders.
    Szodoray P; Nakken B; Barath S; Csipo I; Nagy G; El-Hage F; Osnes LT; Szegedi G; Bodolay E
    Hum Immunol; 2013 Dec; 74(12):1510-8. PubMed ID: 23974054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.
    Eriksson C; Kokkonen H; Johansson M; Hallmans G; Wadell G; Rantapää-Dahlqvist S
    Arthritis Res Ther; 2011 Feb; 13(1):R30. PubMed ID: 21342502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies are not increased in the early phase of Borrelia infection.
    Spiewak R; Stojek NM; Chmielewska-Badora J
    Ann Agric Environ Med; 2004; 11(1):145-8. PubMed ID: 15236512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ELISA subtypization of anti-ENA autoantibodies in clinical management of autoimmune diseases in Bosnia and Herzegovina.
    Subasic D; Karamehic J; Gavrankapetanovic F; Hodzic H; Kasumovic M; Delic-Sarac M; Prljaca-Zecevic L
    Med Arh; 2009; 63(6):312-6. PubMed ID: 20380108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.